Clinical Trial Update: BrECADD Therapy in Stage 2 B-IV Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial of BrECADD therapy for stage 2 B-IV Hodgkin lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• BrECADD therapy

Snippet

Sponsor: University of Miami | Conditions: Hodgkin Lymphoma, Advanced Hodgkin Lymphoma | Phase 2 | Status: RECRUITING